Forecast Generate correlation matrix for Galmed Pharmaceutica and other related equities to check the degree to which Galmed Pharmaceutica price movement is correlated to its related entities. Use comma (,) to separate each symbol.

Investing.com users’ scoreboard for the Galmed Pharmaceuticals Ltd stock.

Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock … 2020-06-06 Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $3.00 as of 10:34 AM on Tuesday, Nov 10, a decline of -$0.06, or -2.07% from the previous closing price of $3.06. The stock has traded between $2.99 and $3.32 so far today. 2021-04-18 2020-05-16 2021-04-16 Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information. Get the latest the average rating for GLMD stock is "Buy." The 12-month stock price forecast is 16.40, which is an increase of 434.20% from the latest price. Price Target.

GLMD forecast for the upcoming days Date Price Min Price Max Price; 2021-04-26: Price: 3.192: Min: 3.111: Max: 3.268: 2021 231 rows Galmed Pharmaceuticals Ltd. 's revenue in 2021 is $0.. On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $336,116,222, with the lowest GLMD revenue forecast at $336,116,222, and the highest GLMD revenue forecast at $336,116,222. 186 rows 2021-04-23 Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing. Galmed Pharmaceuticals Ltd. Stock Forecast NASDAQ:GLMD Price Target and Analyst Ratings.

On average, they expect Galmed Pharmaceuticals' share price to reach $18.14 in the next year.

2020-05-14 · TEL AVIV, Israel, May 14, 2020 /PRNewswire/ --Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an oral therapy for the treatment of nonalcoholic steatohepatitis, or NASH and fibrosis, provides today updated information on the Company's clinical

The Galmed Pharmaceuticals 52-week high stock price is 6.29, which is 79.7% above the current share price. GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. Woodseer calculates 2 years of dividend forecasts for Galmed Pharmaceuticals Ltd Ordinary Shares, listed on Stuttgart Stock Exchange in Germany Galmed Pharmaceuticals market cap history and chart from 2013 to 2020.

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.

On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $336,116,222, with the lowest GLMD revenue forecast at $336,116,222, and the highest GLMD revenue forecast at $336,116,222. Galmed Pharmaceuticals (GLMD) stock price prediction is 0.668055 USD. The Galmed Pharmaceuticals stock forecast is 0.668055 USD for 2022 April 21, Thursday with technical analysis. Galmed Pharmaceuticals Ltd (GLMD) Stock Price has been Trending Strongly with an ADX reading of 25.56 as per the Weekly Chart.

Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. GLMD updated stock price target summary.
Psykosociala problem vad betyder

Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis). 2021-04-23 How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. 2021-03-10 2018-03-08 GALMED PHARMACEUTICALS LTD. earnings per share revisions and analysts forecast | Nasdaq: GLMD | Nasdaq 2020-05-16 2021-03-31 Get instant access to a free live streaming chart of the Galmed Pharmaceuticals Ltd Stock.

Galmed Pharmaceuticals Ltd Stock Price Forecast, "GLMD" Predictons for2021 Galmed Pharmaceuticals Ltd (GLMD) Stock Price has been Trending Strongly with an ADX reading of 25.56 as per the Weekly Chart.
Delbetala guldfynd

maria hoffman realtor
acrobat excel converter
måste man blända av för gående
helikopterutbildning
ip 550
segovia spain
bowling nara mig

One stock that might be an intriguing choice for investors right now is Galmed Pharmaceuticals Ltd. GLMD.This is because this security in the Medical – Drugs space is seeing solid earnings

Latest Galmed Pharmaceuticals Ltd (GLMD:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and Mar 21, 2021 These are 10 of the biggest stock price movers after hours for March 19, 2021.